These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 6318557

  • 1. Biologic actions and pharmacokinetic studies of auranofin.
    Walz DT, DiMartino MJ, Griswold DE, Intoccia AP, Flanagan TL.
    Am J Med; 1983 Dec 30; 75(6A):90-108. PubMed ID: 6318557
    [Abstract] [Full Text] [Related]

  • 2. The pharmacological profile of auranofin, an orally active gold compound.
    Walz DT, DiMartino MJ, Griswold DE.
    Scand J Rheumatol Suppl; 1983 Dec 30; 51():16-25. PubMed ID: 6426049
    [Abstract] [Full Text] [Related]

  • 3. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM, Clerc D, Bisson M, Medicis P, Massias P.
    Rev Rhum Mal Osteoartic; 1985 Apr 30; 52(4):277-82. PubMed ID: 3923604
    [No Abstract] [Full Text] [Related]

  • 4. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E.
    Med Clin (Barc); 1985 May 25; 84(20):834-9. PubMed ID: 3928990
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Auranofin: experience to date.
    Blodgett RC.
    Am J Med; 1983 Dec 30; 75(6A):86-9. PubMed ID: 6419601
    [Abstract] [Full Text] [Related]

  • 10. Auranofin versus injectable gold. Comparison of pharmacokinetic properties.
    Blocka K.
    Am J Med; 1983 Dec 30; 75(6A):114-22. PubMed ID: 6419592
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agent.
    Dimartino MJ, Walz DT.
    Inflammation; 1977 Jun 30; 2(2):131-42. PubMed ID: 104927
    [Abstract] [Full Text] [Related]

  • 13. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M, Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1984 May 30; 27(5):378-424. PubMed ID: 6426923
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.